With regard to this time issue, conditional Brca1 mouse models that develop mammary tumours with strong resemblance to human BRCA1-mutated breast tumours (Liu et al, 2007; McCarthy et al, 2007) can be very helpful in predicting response and resistance to conventional and targeted therapeutics. This evidence concerns the gene BRCA1 and breast cancer.